Nanoparticles for Cerenkov and Radioluminescent Light Enhancement for Imaging and Radiotherapy
- PMID: 32906838
- PMCID: PMC7559269
- DOI: 10.3390/nano10091771
Nanoparticles for Cerenkov and Radioluminescent Light Enhancement for Imaging and Radiotherapy
Abstract
Cerenkov luminescence imaging and Cerenkov photodynamic therapy have been developed in recent years to exploit the Cerenkov radiation (CR) generated by radioisotopes, frequently used in Nuclear Medicine, to diagnose and fight cancer lesions. For in vivo detection, the endpoint energy of the radioisotope and, thus, the total number of the emitted Cerenkov photons, represents a very important variable and explains why, for example, 68Ga is better than 18F. However, it was also found that the scintillation process is an important mechanism for light production. Nanotechnology represents the most important field, providing nanosctructures which are able to shift the UV-blue emission into a more suitable wavelength, with reduced absorption, which is useful especially for in vivo imaging and therapy applications. Nanoparticles can be made, loaded or linked to fluorescent dyes to modify the optical properties of CR radiation. They also represent a useful platform for therapeutic agents, such as photosensitizer drugs for the production of reactive oxygen species (ROS). Generally, NPs can be spaced by CR sources; however, for in vivo imaging applications, NPs bound to or incorporating radioisotopes are the most interesting nanocomplexes thanks to their high degree of mutual colocalization and the reduced problem of false uptake detection. Moreover, the distance between the NPs and CR source is crucial for energy conversion. Here, we review the principal NPs proposed in the literature, discussing their properties and the main results obtained by the proponent experimental groups.
Keywords: cerenkov luminescence imaging; cerenkov radiation; gold nanoparticles; nanoclusters; nanocompounds; nanoparticles; photodynamic therapy; rare-earth nanoparticles; silica nanoparticles.
Conflict of interest statement
The authors declare no conflict of interest.
Figures




Similar articles
-
Activating TiO2 Nanoparticles: Gallium-68 Serves as a High-Yield Photon Emitter for Cerenkov-Induced Photodynamic Therapy.ACS Appl Mater Interfaces. 2018 Feb 14;10(6):5278-5286. doi: 10.1021/acsami.7b17902. Epub 2018 Feb 5. ACS Appl Mater Interfaces. 2018. PMID: 29368518
-
Computed Cerenkov luminescence yields for radionuclides used in biology and medicine.Phys Med Biol. 2015 Jun 7;60(11):4263-80. doi: 10.1088/0031-9155/60/11/4263. Epub 2015 May 14. Phys Med Biol. 2015. PMID: 25973972
-
Cerenkov-specific contrast agents for detection of pH in vivo.J Nucl Med. 2015 Mar;56(3):483-8. doi: 10.2967/jnumed.114.146605. Epub 2015 Feb 5. J Nucl Med. 2015. PMID: 25655631 Free PMC article.
-
Optical imaging of radioisotopes: a novel multimodal approach to molecular imaging.Q J Nucl Med Mol Imaging. 2012 Jun;56(3):280-90. Q J Nucl Med Mol Imaging. 2012. PMID: 22695338 Review.
-
Cerenkov imaging.Adv Cancer Res. 2014;124:213-34. doi: 10.1016/B978-0-12-411638-2.00006-9. Adv Cancer Res. 2014. PMID: 25287690 Free PMC article. Review.
Cited by
-
The United States Department of Energy and National Institutes of Health Collaboration: Medical Care Advances by Discovery in Radiation Detection.Med Phys. 2024 Dec;51(12):8654-8669. doi: 10.1002/mp.17333. Epub 2024 Aug 23. Med Phys. 2024. PMID: 39177300
-
A brief review of reporter gene imaging in oncolytic virotherapy and gene therapy.Mol Ther Oncolytics. 2021 Mar 10;21:98-109. doi: 10.1016/j.omto.2021.03.006. eCollection 2021 Jun 25. Mol Ther Oncolytics. 2021. PMID: 33981826 Free PMC article. Review.
-
Psoralen as a Photosensitizers for Photodynamic Therapy by Means of In Vitro Cherenkov Light.Int J Mol Sci. 2022 Dec 3;23(23):15233. doi: 10.3390/ijms232315233. Int J Mol Sci. 2022. PMID: 36499568 Free PMC article.
-
Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations.Pharmaceutics. 2024 Apr 13;16(4):534. doi: 10.3390/pharmaceutics16040534. Pharmaceutics. 2024. PMID: 38675195 Free PMC article.
-
Application of TD-DFT Theory to Studying Porphyrinoid-Based Photosensitizers for Photodynamic Therapy: A Review.Molecules. 2021 Nov 26;26(23):7176. doi: 10.3390/molecules26237176. Molecules. 2021. PMID: 34885763 Free PMC article. Review.
References
-
- Ma X., Wang J., Cheng Z. Cerenkov radiation: A multi-functional approach for biological sciences. Front. Phys. 2014;2:1–14. doi: 10.3389/fphy.2014.00004. - DOI
Publication types
LinkOut - more resources
Full Text Sources